Primary care experience on Rinfodim 3® in children with recurrent respiratory infections

E. Poggi, A. Giannattasio, M. E. Cartosio, R. Campus, G. Ciprandi

Article ID: 4968
Vol 34, Issue 6, 2020
DOI: https://doi.org/10.23812/20-474-L
Received: 8 January 2021; Accepted: 8 January 2021; Available online: 8 January 2021; Issue release: 8 January 2021

Keywords

Lactobacillus rhamnosus GG ATCC 53103;children;docosahexaenoic acid;immune system;primary care;real-world;recurrent respiratory infection;vitamin D3


References

Supporting Agencies



Copyright (c) 2020 E. Poggi, A. Giannattasio, M. E. Cartosio, R. Campus, G. Ciprandi




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).